BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3690389)

  • 1. Renal actions of angiotensin II in renovascular hypertension.
    Anderson WP; Woods RL; Denton KM; Alcorn D
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1559-65. PubMed ID: 3690389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and systemic effects of enalapril in chronic one-kidney hypertension.
    Woods RL; Anderson WP; Korner PI
    Hypertension; 1986 Feb; 8(2):109-16. PubMed ID: 3002979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of glomerular filtration rate: role of intrarenally formed angiotensin II.
    Kastner PR; Hall JE; Guyton AC
    Am J Physiol; 1984 Jun; 246(6 Pt 2):F897-906. PubMed ID: 6377913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.
    van Twist DJ; Houben AJ; de Haan MW; de Leeuw PW; Kroon AA
    J Hypertens; 2016 Jun; 34(6):1160-9. PubMed ID: 27032075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II and the maintenance of GFR and renal blood flow during renal artery narrowing.
    Anderson WP; Denton KM; Woods RL; Alcorn D
    Kidney Int Suppl; 1990 Nov; 30():S109-13. PubMed ID: 2259068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of renovascular hypertension.
    Robertson JI; Morton JJ; Tillman DM; Lever AF
    J Hypertens Suppl; 1986 Oct; 4(4):S95-103. PubMed ID: 3534187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats.
    Oliveira-Sales EB; Varela VA; Maquigussa E; Borges FT; Shimoura CG; Gomes G; Campos RR; Boim MA
    Clin Exp Hypertens; 2016; 38(7):586-593. PubMed ID: 27649588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renovascular hypertension: information from experiments using conscious dogs.
    Anderson WP; Woods RL; Gao Y
    Clin Exp Pharmacol Physiol; 1991 Jan; 18(1):29-32. PubMed ID: 2032386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin sensitivity and prostaglandins in dogs with renal hypertension.
    Watson ML; McCormick J; Ungar A
    J Hypertens; 1984 Oct; 2(5):479-83. PubMed ID: 6530552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate renal function studies in conscious dogs with renovascular hypertension.
    DeForrest JM; Davis JO; Freeman RH; Watkins BE; Stephens GA
    Am J Physiol; 1978 Oct; 235(4):F310-6. PubMed ID: 696870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
    Hartono SP; Knudsen BE; Lerman LO; Textor SC; Grande JP
    BMC Nephrol; 2014 Apr; 15():58. PubMed ID: 24708836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The captopril glomerular filtration rate renogram in renovascular hypertension.
    Wilcox CS; Smith TB; Frederickson ED; Wingo CD; Phillips MI; Williams CM
    Clin Nucl Med; 1989 Jan; 14(1):1-7. PubMed ID: 2653686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renovascular hypertension: clinical concepts.
    Fenves AZ; Ram CV
    Minerva Med; 2006 Aug; 97(4):313-24. PubMed ID: 17008836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of angiotensin II in the development of hypertension and in the maintenance of glomerular filtration rate during 48 hours of renal artery stenosis in conscious dogs.
    Selig SE; Anderson WP; Korner PI; Casley DJ
    J Hypertens; 1983 Aug; 1(2):153-8. PubMed ID: 6099382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrarenal effects of angiotensin II in renal artery stenosis.
    Anderson WP; Woods RL
    Kidney Int Suppl; 1987 May; 20():S157-67. PubMed ID: 3298798
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of prostaglandins and angiotensin II: effects on renal function in hypertensive patients.
    Fommei E; Ghione S; Palla L; Ragazzini A; Gazzetti P; Palombo C; Giaconi S
    Agents Actions Suppl; 1987; 22():183-9. PubMed ID: 3324707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.